Kelly M Cordoro

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications
    Kelly M Cordoro
    Department of Dermatology, Division of Pediatric Dermatology, University of California, San Francisco, California 94115, USA
    J Am Acad Dermatol 60:669-75. 2009
  2. ncbi Management of childhood psoriasis
    Kelly M Cordoro
    University of California, San Francisco, 1701 Divisadero Street, Box 0316, San Francisco, CA 94115, USA
    Adv Dermatol 24:125-69. 2008
  3. ncbi Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms
    Cheryl Lundeberg Lonergan
    Department of Dermatology, University of Virginia Health System, Charlottesville, USA
    Cutis 85:199-202. 2010
  4. ncbi Trends in pediatric psoriasis outpatient health care delivery in the United States
    Sinae A Vogel
    School of Medicine, University of California, San Francisco, San Francisco, CA 94115, USA
    Arch Dermatol 148:66-71. 2012
  5. ncbi To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis
    William Huang
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1071, USA
    J Am Acad Dermatol 58:970-7. 2008

Collaborators

Detail Information

Publications5

  1. ncbi Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications
    Kelly M Cordoro
    Department of Dermatology, Division of Pediatric Dermatology, University of California, San Francisco, California 94115, USA
    J Am Acad Dermatol 60:669-75. 2009
    ....
  2. ncbi Management of childhood psoriasis
    Kelly M Cordoro
    University of California, San Francisco, 1701 Divisadero Street, Box 0316, San Francisco, CA 94115, USA
    Adv Dermatol 24:125-69. 2008
    ..Patient advocacy and education groups, such as the National Psoriasis Foundation (www.psoriasis.org; 800-723-9166) are excellent resources and can serve as an extension of your comprehensive care...
  3. ncbi Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms
    Cheryl Lundeberg Lonergan
    Department of Dermatology, University of Virginia Health System, Charlottesville, USA
    Cutis 85:199-202. 2010
    ....
  4. ncbi Trends in pediatric psoriasis outpatient health care delivery in the United States
    Sinae A Vogel
    School of Medicine, University of California, San Francisco, San Francisco, CA 94115, USA
    Arch Dermatol 148:66-71. 2012
    ..To characterize patterns of childhood psoriasis health care delivery from 1979-2007...
  5. ncbi To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis
    William Huang
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1071, USA
    J Am Acad Dermatol 58:970-7. 2008
    ..Ultimately, from a practical standpoint, it is incumbent on the clinician to consider each patient independently and determine what screening tests are most appropriate for each individual patient...